tirzepatide and adhd medication GLP-1s & Meds: Safety, Timing & Focus Eli Lilly Launches Self-Pay Vials

Now lets turn to the SELECT trial, whose results were published in the New England Journal of Medicine in 2023

The findings here highlight that to maintain weight loss, people should continue on tirzepatide long-term, says Fatima Cody Stanford, MD, MPH, an associate professor of medicine at Harvard Medical School and obesity medicine specialist at Massachusetts General Hospital, both in Boston

Although rare, some reports have indicated that GLP-1 agonists, including semaglutide, could increase the risk of macular edema in people with diabetes

There's no single FDA-approved dosing protocol dosing is based on smaller studies, nutrient requirements, and clinical experience across compounding pharmacies